Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters











Database
Language
Publication year range
1.
Biomicrofluidics ; 8(3): 036501, 2014 May.
Article in English | MEDLINE | ID: mdl-24926391

ABSTRACT

Detection of individual target cells among a large amount of blood cells is a major challenge in clinical diagnosis and laboratory protocols. Many researches show that two dimensional cells array technology can be incorporated into routine laboratory procedures for continuously and quantitatively measuring the dynamic behaviours of large number of living cells in parallel, while allowing other manipulations such as staining, rinsing, and even retrieval of targeted cells. In this study, we present a high-density cell self-assembly technology capable of quickly spreading over 300 000 cells to form a dense mono- to triple-layer cell arrangement in 5 min with minimal stacking of cells by the gentle incorporation of gravity and peripheral micro flow. With this self-assembled cell arrangement (SACA) chip technology, common fluorescent microscopy and immunofluorescence can be utilized for detecting and analyzing target cells after immuno-staining. Validated by experiments with real human peripheral blood samples, the SACA chip is suitable for detecting rare cells in blood samples with a ratio lower than 1/100 000. The identified cells can be isolated and further cultured in-situ on a chip for follow-on research and analysis. Furthermore, this technology does not require external mechanical devices, such as pump and valves, which simplifies operation and reduces system complexity and cost. The SACA chip offers a high-efficient, economical, yet simple scheme for identification and analysis of rare cells. Therefore, potentially SACA chip may provide a feasible and economical platform for rare cell detection in the clinic.

2.
PLoS One ; 8(8): e71718, 2013.
Article in English | MEDLINE | ID: mdl-23977125

ABSTRACT

Anthrax is a disease caused by the bacterium Bacillus anthracis, which results in high mortality in animals and humans. Although some of the mechanisms are already known such as asphyxia, extensive knowledge of molecular pathogenesis of this disease is deficient and remains to be further investigated. Lethal toxin (LT) is a major virulence factor of B. anthracis and a specific inhibitor/protease of mitogen-activated protein kinase kinases (MAPKKs). Anthrax LT causes lethality and induces certain anthrax-like symptoms, such as anemia and hypoxia, in experimental mice. Mitogen-activated protein kinases (MAPKs) are the downstream pathways of MAPKKs, and are important for erythropoiesis. This prompted us to hypothesize that anemia and hypoxia may in part be exacerbated by erythropoietic dysfunction. As revealed by colony-forming cell assays in this study, LT challenges significantly reduced mouse erythroid progenitor cells. In addition, in a proteolytic activity-dependent manner, LT suppressed cell survival and differentiation of cord blood CD34(+)-derived erythroblasts in vitro. Suppression of cell numbers and the percentage of erythroblasts in the bone marrow were detected in LT-challenged C57BL/6J mice. In contrast, erythropoiesis was provoked through treatments of erythropoietin, significantly ameliorating the anemia and reducing the mortality of LT-treated mice. These data suggested that suppressed erythropoiesis is part of the pathophysiology of LT-mediated intoxication. Because specific treatments to overcome LT-mediated pathogenesis are still lacking, these efforts may help the development of effective treatments against anthrax.


Subject(s)
Anthrax/microbiology , Anthrax/pathology , Antigens, Bacterial/toxicity , Bacterial Toxins/toxicity , Disease Progression , Erythropoiesis/drug effects , Anemia/complications , Anemia/pathology , Animals , Anthrax/complications , Apoptosis/drug effects , Biocatalysis/drug effects , Cell Differentiation/drug effects , Colony-Forming Units Assay , Erythroid Cells/drug effects , Erythroid Cells/metabolism , Erythroid Cells/pathology , Erythropoietin/pharmacology , Hemolysis/drug effects , Humans , Male , Mice , Mice, Inbred C57BL , Proteolysis/drug effects , Survival Analysis
3.
PLoS One ; 8(3): e59512, 2013.
Article in English | MEDLINE | ID: mdl-23555687

ABSTRACT

Anthrax lethal toxin (LT) is a major virulence factor of Bacillus anthracis. LT challenge suppresses platelet counts and platelet function in mice, however, the mechanism responsible for thrombocytopenia remains unclear. LT inhibits cellular mitogen-activated protein kinases (MAPKs), which are vital pathways responsible for cell survival, differentiation, and maturation. One of the MAPKs, the MEK1/2-extracellular signal-regulated kinase pathway, is particularly important in megakaryopoiesis. This study evaluates the hypothesis that LT may suppress the progenitor cells of platelets, thereby inducing thrombocytopenic responses. Using cord blood-derived CD34(+) cells and mouse bone marrow mononuclear cells to perform in vitro differentiation, this work shows that LT suppresses megakaryopoiesis by reducing the survival of megakaryocytes. Thrombopoietin treatments can reduce thrombocytopenia, megakaryocytic suppression, and the quick onset of lethality in LT-challenged mice. These results suggest that megakaryocytic suppression is one of the mechanisms by which LT induces thrombocytopenia. These findings may provide new insights for developing feasible approaches against anthrax.


Subject(s)
Antigens, Bacterial/toxicity , Bacterial Toxins/toxicity , Megakaryocytes/cytology , Megakaryocytes/drug effects , Animals , Antigens, CD34/metabolism , Cell Death/drug effects , Fetal Blood/cytology , Humans , Male , Megakaryocytes/metabolism , Mice , Stem Cells/cytology , Stem Cells/drug effects , Thrombocytopenia/chemically induced , Thrombocytopenia/drug therapy , Thrombopoietin/pharmacology , Thrombopoietin/therapeutic use
4.
Mater Sci Eng C Mater Biol Appl ; 33(2): 989-95, 2013 Mar 01.
Article in English | MEDLINE | ID: mdl-25427516

ABSTRACT

Functionalized multi-walled carbon nanotubes (f-MWCNTs) were conjugated to an antibody of BT-474 cancer cells (f-MWCNTs-ab), and the photothermal effect of the f-MWCNTs-ab for BT-474 cancer cell destruction was demonstrated. After near-infrared irradiation, the f-MWCNTs-ab were more capable of killing cancer cells and possessed higher cell specificity than f-MWCNTs. Quantitative results showed that the viability of the cancer cells was affected by the concentration of the f-MWCNTs-ab solution, irradiation time, and settling time after irradiation. The membrane impermeable fluorescence dye ethidium bromide was used to detect cell viability after near-infrared irradiation, and the results agreed with those obtained from the Alamar Blue cell viability assay. The EtBr fluorescence results suggest that the cell membrane, attached to f-MWCNTs-ab, was damaged after irradiation, which led to cell death and necrosis. Using confocal microscopy, a few f-MWCNTs-ab were detected in the cell, indicating the endocytosis effect. The results not only explain the improved efficiency of thermotherapy but also indicate that necrosis may result from protein denaturation attributing to the heated f-MWCNTs-ab in the cell.


Subject(s)
Antineoplastic Agents/pharmacology , Cell Survival/drug effects , Cell Survival/radiation effects , Nanotubes, Carbon/chemistry , Photochemical Processes , Antibodies/chemistry , Antibodies/metabolism , Antineoplastic Agents/chemistry , Cell Line, Tumor , Hot Temperature , Humans , Infrared Rays , Lasers
5.
J Lab Autom ; 18(1): 69-76, 2013 Feb.
Article in English | MEDLINE | ID: mdl-22496249

ABSTRACT

Techniques to separate cells are widely applied in immunology. The technique to separate a specific antigen on a microfluidic platform involves the use of a shear horizontal surface-acoustic-wave (SH-SAW) sensor. With specific antibodies conjugated onto the surface of the SH-SAW sensors, this technique can serve to identify specific cells in bodily fluids. Jurkat cells, used as a target in this work, provide a model of cells in small abundance (1:1000) for isolation and purification with the ultimate goal of targeting even more dilute cells. T cells were separated from a mixed-cell medium on a chip (Jurkat cells/K562 cells, 1/1000). A novel microchamber was developed to capture cells during the purification, which required a large biosample. Cell detection was demonstrated through the performance of genetic identification on the chip.


Subject(s)
Acoustics/instrumentation , Antigens/metabolism , Biosensing Techniques/instrumentation , Biosensing Techniques/methods , Cells/cytology , Cells/metabolism , Shear Strength , Antibodies/metabolism , Humans , Jurkat Cells , K562 Cells , Optical Imaging , Propylamines , Silanes/chemistry , Silicon Dioxide/chemistry , Surface Properties , Water/chemistry
6.
J Cell Physiol ; 226(7): 1750-62, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21506107

ABSTRACT

Many tumor cells are capable of migrating through endothelial cell (EC) junctions and disintegrating sub-endothelial extracellular matrix to achieve extravasation. We demonstrate in this study that certain solid tumor cells can induce EC apoptosis to facilitate their escape from the circulation. The EC apoptosis is triggered by elevated intracellular reactive oxygen species (ROS) levels and direct contacts with tumor cells are required. Treating ECs with antioxidants, such as ascorbate and N-acetyl-L-cysteine (NAC), and a glutathione precursor can rescue the ECs from tumor-induced apoptosis and reduce the number of tumor cells migrating across endothelial barriers. NAD(P)H oxidase was identified as the major ROS producer in the event since inhibitors and small interference RNA specific to the enzyme could abrogate the tumor-induced ROS production and hence EC death. This study also provides evidence showing that the interaction between tumor and EC increases intracellular Ca(2+) concentration and activates protein kinase C (PKC) activity, which leads to NAD(P)H oxidase activation through the serine-phosphorylation of p47(phox) subunit. These findings suggest that blocking the tumor-induced EC apoptosis is a potential way to prevent tumor metastasis.


Subject(s)
Apoptosis , Cell Communication , Cell Movement , Endothelial Cells/enzymology , NADPH Oxidases/metabolism , Neoplasms/metabolism , Oxidative Stress , Reactive Oxygen Species/metabolism , Animals , Antioxidants/pharmacology , Apoptosis/drug effects , Calcium/metabolism , Cell Communication/drug effects , Cell Movement/drug effects , Coculture Techniques , Endothelial Cells/drug effects , Endothelial Cells/pathology , Enzyme Activation , Enzyme Inhibitors/pharmacology , HeLa Cells , Hep G2 Cells , Humans , NADPH Oxidases/antagonists & inhibitors , NADPH Oxidases/genetics , Neoplasm Invasiveness , Neoplasms/pathology , Oxidative Stress/drug effects , Phosphorylation , Protein Kinase C/metabolism , RNA Interference , Rats , Serine , Time Factors , Transfection
7.
Exp Cell Res ; 316(17): 2893-902, 2010 Oct 15.
Article in English | MEDLINE | ID: mdl-20691680

ABSTRACT

UDP-glucose dehydrogenase (UGDH) catalyzes oxidation of UDP-glucose to yield UDP-glucuronic acid, a precursor of hyaluronic acid (HA) and other glycosaminoglycans (GAGs) in extracellular matrix. Although association of extracellular matrix with cell proliferation and migration has been well documented, the importance of UGDH in these behaviors is not clear. Using UGDH-specific small interference RNA to treat HCT-8 colorectal carcinoma cells, a decrease in both mRNA and protein levels of UGDH, as well as the cellular UDP-glucuronic acid and GAG production was observed. Treatment of HCT-8 cells with either UGDH-specific siRNA or HA synthesis inhibitor 4-methylumbelliferone effectively delayed cell aggregation into multicellular spheroids and impaired cell motility in both three-dimensional collagen gel and transwell migration assays. The reduction in cell aggregation and migration rates could be restored by addition of exogenous HA. These results indicate that UGDH can regulate cell motility through the production of GAG. The enzyme may be a potential target for therapeutic intervention of colorectal cancers.


Subject(s)
Cell Movement , Colorectal Neoplasms/metabolism , Glycosaminoglycans/biosynthesis , Uridine Diphosphate Glucose Dehydrogenase/genetics , Cell Adhesion , Cell Line, Tumor , Down-Regulation/genetics , Extracellular Matrix/metabolism , Humans , Hyaluronic Acid/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL